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Abstract
Coronary collateral growth (arteriogenesis) is a physiological adaptive response to transient and repetitive occlusion of
major coronary arteries in which small arterioles (native collaterals) with minimal to no blood flow remodel into larger
conduit arteries capable of supplying adequate perfusion to tissue distal to the site of occlusion. The ability to reliably and
reproducibly mimic transient, repetitive coronary artery occlusion (ischemia) in animal models is critical to the development
of therapies to restore coronary collateral development in type II diabetes and the metabolic syndrome. Current animal
models for repetitive coronary artery occlusion implement a pneumatic occluder (balloon) that is secured onto the surface
of the heart with the suture, which is inflated manually, via a catheter connected to syringe, to effect occlusion of the left
anterior descending coronary artery (LAD). This method, although effective, presents complications in terms of
reproducibility and practicality. To address these limitations, we have designed a device for automated, transient inflation
of balloon catheters in coronary artery occlusion models. This device allows repeated, consistent inflation (to either specified
pressure or volume) and the capability for implementing very complex, month-long protocols. This system has significantly
increased the reproducibility of coronary collateral growth studies in our laboratory, resulting in a significant decrease in the
numbers of animals needed to complete each study while relieving laboratory personnel from the burden of extra working
hours and enabling us to continue studies over periods when we previously could not. In this paper, we present all details
necessary for construction and operation of the inflator. In addition, all of the components for this device are commercially
available and economical (Table S1). It is our hope that the adoption of automated balloon catheter inflation protocols will
improve the experimental reliability of transient ischemia studies at many research institutions.
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Introduction
Type II diabetes and the metabolic syndrome – a cluster of risk
factors including abdominal obesity, insulin resistance, hypergly-
cemia, dyslipidemia and hypertension – affect ,30% of the U.S.
population with increasing prevalence [1]. These pathologies are
also associated with increased severity of ischemic coronary artery
disease (CAD). For example, higher numbers of metabolic
syndrome components have been correlated with more severe
CAD [1,2] and increased CAD-associated mortality. Patients with
type II diabetes are ,2 times more likely to die of CAD, whereas
patients with all component pathologies of the metabolic
syndrome are ,3.6–4.4 times more likely to die of CAD [3,4].
Moreover, current revascularization therapies, coronary artery
bypass grafting (CABG), and percutaneous transluminal coronary
angioplasty (PTCA) in type II diabetics and metabolic syndrome
patients are associated with higher procedural risk and poorer
long-term outcomes then in patients without type II diabetes or the
metabolic syndrome [5–7].
Coronary collateral growth (arteriogenesis) is a physiological
adaptive response to transient and repetitive occlusion of major
coronary arteries in which small arterioles (native collaterals) with
minimal to no blood flow remodel into larger conduit arteries
capable of supplying adequate perfusion to tissue distal to the site
of occlusion. Transient repetitive coronary artery occlusion and
resultant myocardial ischemia stimulate coronary collateral growth
in healthy humans and normal animals [8–11]. Clinically, patients
with stable angina have decreased incidence of fatal myocardial
infarction, which is associated with better developed collateral
networks [8]. In addition, well-developed collateral networks seem
to promote long term patency of coronary bypass grafts. However,
this normal physiological response is impaired in patients with type
II diabetes and the metabolic syndrome [12–15]. Graft closure,
and consequent need for revascularization, is a significant problem
in type II diabetic and metabolic syndrome patients [6].
Therefore, the ability to reliably and reproducibly mimic transient,
repetitive coronary artery ischemia in animal models is critical to
the development of therapies to restore coronary collateral
development in type II diabetes and the metabolic syndrome.
Like in human metabolic syndrome, coronary collateral growth
has been shown to be impaired in most animal models of the
metabolic syndrome [10,16–18]. However, normal collateral
development has been reported in a swine model of the metabolic
syndrome [19]. The most obvious difference in the swine model is
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that this was a model of progressive chronic ischemia whereas the
other animal models used transient, repetitive coronary artery
occlusion to stimulate collateral development, which mimics the
pathophysiology of the human. Since the exact timing and
duration of coronary occlusions has been associated with the
extent of collateral growth [20,21], the difference between these
two methods of inducing coronary occlusion is a likely explanation
for the different outcomes between the models and emphasizes the
necessity of using transient and repetitive coronary occlusion
models vs. progressive occlusion (ameroid constrictors) when
studying coronary collateral development.
We and others have recently successfully used both normal and
metabolic syndrome rat models of transient, repetitive left anterior
descending coronary artery (LAD) occlusion to study coronary
collateral development [10,16,18,22–25]. A pneumatic occluder
(balloon) is secured onto the surface of the heart with the suture,
which is also passed under the LAD so that when the balloon is
inflated, the LAD is occluded [23]. The occluder has a catheter,
which is externalized for easy access for manual inflation, using an
air-filled syringe, post-surgically. This method, although effective,
presents complications in terms of reproducibility and practicality.
Most significantly, manual inflation allows for regulation of the
volume of air injected into the occluder but provides no indication
of consistent pressure from animal to animal. Since occluders are
manufactured individually and manually, some variation in their
size is inevitable. Therefore, despite identical volumes being
injected, the varying inflation pressure and consequent varying
extent of LAD occlusion introduces a small, yet unnecessary
confounding variable into the experimental design. Secondly, it
can be difficult to maintain a stringent schedule demanded by
manual occlusion inflation protocols for periods of several weeks or
months, especially in smaller laboratories. Because the timing and
duration of transient coronary occlusions has been associated with
the extent of collateral growth (as mentioned above), these small
variations in LAD occlusion or frequency may also effect
variations in the extent of collateral growth.
To overcome these obstacles, we have developed an automated
inflation system. This system allows reproducible pressurized
inflation of up to four pneumatic occluders simultaneously. In
addition, complex and varied experimental protocols can be
defined including inflation times, repetition rates, resting times,
and the number of cycles for each occlusion protocol (of up to
indefinite duration). This system has significantly increased the
reproducibility of coronary collateral growth studies in our
laboratory, resulting in a significant decrease in the numbers of
animals needed to complete each study while relieving laboratory
personnel from the burden of extra working hours and enabling us
to continue studies over periods when we previously could not.
In this paper, we describe the construction and operation of a
device for automated inflation of pneumatic occluders in transient
LAD ischemia studies. The device consists of electronics and
pneumatics hardware, and corresponding control software. Each
element of the device is described in detail, so as to allow
construction of similar devices at other research institutions. In
addition, a detailed list of all components, with supplier, and
description of the operating software are included in the
supplemental information. All of the components for this device
are commercially available, with a total cost of under $1300 (U.S.,
not including computer). It is our hope that the adoption of
automated balloon catheter inflation protocols will improve the
experimental reliability of transient ischemia studies at many
research institutions.
Materials and Methods
The automated balloon catheter inflation device consisted of an
electronic subsystem, an pneumatic subsystem, and control
software with corresponding user interface. The control software
communicated with the electronic subsystem via an USB interface
board. The electronic subsystem supplied power to solenoid
pressure valves, which controlled the pressurizing and depressur-
izing of the balloon catheters. A list of the parts required for the
automated catheter inflation device is given in Table S1.
Electronic Subsystem
The electronic subsystem consisted of an USB interface (USB-
6009, National Instruments, Inc.), 24V DC power supply (VOF-
25-24, CUI, Inc.), and TTL-controlled 24V relay board (RLY102-
24V, Winford Engineering), along with supporting electrical
components (Figure 1). Digital input/output lines from the USB
interface were used to switch the relays, controlling 24 V power to
the solenoid valves. A snubber circuit was used for each solenoid,
consisting of a diode connected in reverse polarity from the
negative terminal of the solenoid to the positive DC voltage
supply. This circuit protects against high reverse potentials
generated from solenoid closing. AC Power to the 24 V supply
(and hence, the relay board) was controlled by a manual switch.
An air flow meter (D6F-01A1-110, Omron) was used to
measure the volume of air delivered. The flow meter output
signal was read via an analog input (0–5 V, 14 bit) and integrated
using a Labview script (see Control Software section).
All components for the electronic subsystem were placed in a
water-tight enclosure. Water-resistant electrical fittings were used
for the solenoid valve and flow meter connections.
Pneumatic Subsystem
The pneumatic subsystem consisted of a master pressure control
valve, two solenoid valves, the flow meter, and the pressure
manifold (Figure 2). Using the dual relay, the two solenoid valves
could be operated independently. Three valve combinations were
used for catheter inflation: 1) the first solenoid valve (component
(7) in Figure 2) was opened and the second solenoid valve
(component (8) in Figure 2) was closed, allowing pressurized air to
flow into the catheters; 2) the first and second solenoid valves were
both closed, maintaining a fixed pressure within the catheters
balloons, 3) the first solenoid valve was closed and the second
solenoid valve was opened, allowing pressurized air to vent to the
atmosphere. Valves were kept in the third configuration between
inflation cycles, allowing balloon catheters to remain deflated.
Control Software
Control software was written using Labview software (National
Instruments, Inc.). The control software consisted of a series of
timed loops, implementing a series of balloon inflation and
deflation cycles (see Figure S1 for a detailed description). A user
interface was also generated using Labview software, in order to
facilitate changing the inflation protocol for different experiments.
The factory calibration for the flowmeter was also applied using
the control software, using a signal scaling function. The calibrated
signal was then integrated to yield a measure of the total air
volume delivered. The exact Labview functions for performing
these steps are shown in Figure S1.
Comparison of Manual and Automated Balloon Catheter
Inflation
Variation in collateral dependent blood flow in rat repetitive
myocardial ischemia (RI) studies was used as an indicator of
An Automated Balloon Catheter Inflator
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balloon catheter inflation reproducibility. Data was tabulated from
both unpublished and published [23–26] results from our group.
Inclusion criteria for the retrospective comparison included:
matching the mouse line (different breeds may introduce inherit
physiological variance), matching the study protocol, and match-
ing (as closely as possible) the sample size for the study. Two of the
more recent automated inflation experiments performed by our
group [24,27] were excluded, as these studies involved much
smaller sample sizes than the manual inflation studies (n = 5 vs.
n = 12, respectively). Blood flow measurements were performed
using either radioactive microspheres or gold-labeled and samar-
ium-labeled microspheres, as described previously [23,25] (for
unpublished results, the methodology is described in detail in the
following sub-sections). Data from two rat lines was used for
comparison: Wistar Kyoto (WKY) rats and Sprague-Dawley (SD)
rats. For both rat lines, collateral dependent blood flow
measurements were made either before and after RI or in RI-
affected collateral zone (CZ) and normal zone (NZ) tissues. All
measurements were made using both manual inflation and the
automated balloon catheter inflation device described in these
studies.
Rat model of coronary collateral growth (CCG)/repetitive
ischemia (RI). Male, 10–12 week old Sprague-Dawley (SD;
Charles Rivers, Wilmington, MA) (300–350 g) were used for
chronic (9 days) implantation of a pneumatic occluder over the left
anterior descending coronary artery (LAD). A suture was passed
under the proximal portion of the LAD and the occluder was sown
onto the surface of the heart. The occluder catheter was
externalized between the scapulae. When the occluder is inflated,
the suture is pulled towards the surface of the heart and the LAD is
occluded. The LAD perfusion territory is termed the collateral-
dependent zone (CZ) because perfusion in this area, while the
LAD is occluded, depends on the development of coronary
collaterals. The animals underwent a RI protocol consisting of
eight 40 sec occlusions, once every 20 min (2 h, 20 min total)
Figure 1. Electronic subsystem schematic. Red lines indicate positive voltage supply (+), black lines indicate negative (2), and blue lines indicate
control (digital TTL or analog 0–5 V). Component images for the USB interface (1), relay board (2), and 24 VDC power supply (3), are taken from
National Instruments [28], CUI [29], and Winford Engineering [30], respectively.
doi:10.1371/journal.pone.0095823.g001
Figure 2. Pneumatic subsystem schematic: main pressure valve
(4), pressure dial (5), pressure regulator (6), pressurizing
solenoid valve (7), venting solenoid valve (8), pressure
manifold (9), and air flow meter (10). Solid lines indicate
pneumatic connections. Dashed lines indicate electrical connections
(see Figure 1).
doi:10.1371/journal.pone.0095823.g002
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followed by a rest period of 5 h, 40 min. This 8-hour cycle was
repeated 3 times/day for 0–9 days. Surgical procedures were
performed in accordance with the Animal Welfare Act and are
approved by the IACUC of the University of South Alabama.
Myocardial and collateral-dependent blood flow
measurements. Color microspheres (56105, 15 mM diameter)
labeled with samarium (day 0 RI (initial surgery) or gold (day 10
RI) or radioactive microspheres (56105, 15 mM diameter) labeled
with 57Co (day 0 RI (initial surgery) or 103Ru (day 10 RI) were
injected into the LV during LAD occlusion. There are no
differences in blood flows measured by colored or radioactive
microspheres. Arterial reference blood samples (carotid) and heart
tissue from the NZ and the CZ were collected, weighed and sent to
BioPal (Worcester, MA) for analysis. Blood flows to the NZ and
the CZ (ml/min/g) were calculated from the formula: Blood
Flow = [(radioactive counts in myocardial tissue)X(blood reference
withdrawal rate)/(radioactive count in blood reference)]/(weight
of myocardial tissue). Results were analyzed by calculating the
standard error of the mean (SEM):
Figure 3. The automated catheter inflation device (A) and
example of cardiac ischemia study using the device (B). The
curved arrows indicate the pressure lines which exit from the manifold
in (A) and are connected to the implanted balloon catheters in (B) via
rotating couplers.
doi:10.1371/journal.pone.0095823.g003
Figure 4. The completed balloon catheter inflation device
consists of: the USB interface (1), relay board (2), 24 VDC
power supply (3), main pressure valve (4), pressure dial (5),
pressure regulator (6), pressurizing solenoid valve (7), venting
solenoid valve (8), pressure manifold (9), and air flow meter
(10). Components 1–3 comprise the electronic system while compo-
nents 4–10 comprise the pneumatic subsystem.
doi:10.1371/journal.pone.0095823.g004
Figure 5. Detailed photograph of the electronics control
system: the USB interface (1), relay board (2), and 24 VDC
power supply (3).
doi:10.1371/journal.pone.0095823.g005
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where SD is the standard deviation and n is the number of





where m is the mean value. The CV was used as a metric to
characterize the reproducibility of each study evaluated.
Results
System Description
The automated catheter inflation device provided consistent
inflation volumes and balloon pressures. The manifold allowed up
to four catheters to be inflated and deflated simultaneously
(Figure 3). All components were integrated on a 2 ft62 ft piece of
Plexiglas for easy transport (Figure 4). 120 VAC and 24 VDC wire
connections were enclosed in appropriate connectors or solder
connections were enclosed in heat-shrink tubing to minimize the
risk for short circuits. The electronic subsystem was placed in a
water-tight enclosure (Figure 5).
The user interface allowed relatively complex or lengthy
experimental protocols to be performed automatically – up to
several weeks in duration (Figure 6). The user interface also
allowed for monitoring of the protocol progress through a series of
counters and timers. The software was compiled into an
executable file (with a corresponding installer) that could be run
on any windows-based computer.
Comparison of Manual and Automated Balloon Catheter
Inflation
One of the central outcomes of automated balloon catheter
inflation is to ensure reproducible occlusion during repetitive
myocardial ischemia (RI) studies. A key outcome of these studies is
the development of coronary collateral growth, which can be
assessed through the measurement of collateral dependent blood
flow. Hence, variation in collateral dependent flow among animals
in the same study group is one of the most important indicators of
the reproducibility of balloon catheter inflation experiments. We
have previously performed manual inflation protocols in WKY
rats that resulted in collateral dependent blood flows of
0.2660.09 mL/min/g (6 indicates standard error of the mean
(SEM); coefficient of variation (CV) = 1.038) and 1.6360.3
(CV = 0.552) for pre- and post-RI, respectively (n = 9 animals)
[23]. We have more recently performed these same protocols
using the automated inflation device described in this paper,
resulting in collateral dependent blood flows of 0.1560.03
(CV = 0.470) and 2.0460.05 (CV = 0.064) for pre- and post-RI,
respectively (n = 6, see Figure 7, A–C for graphical representation)
[25]. Similar studies were attempted using Sprague-Dawley rats,
where manual studies resulted in highly variant blood flows
(CV = 0.523 and 0.463) that were not publishable, even with a
Figure 6. The software user interface (Labview front panel) allows the user to adjust parameters for automated inflation: the
catheter pressurization (balloon filling time); the duration that the catheter remains inflated (inflation time); the interval between
subsequent, shortly-spaced inflations in a cycle (inflation interval); the number of inflations per cycle (inflations/cycle); the interval
between cycles (cycle interval); and the total number of cycles. For each of these sequences, a timer or counter displays the progress of the
automated inflation. A bar plot displays the inflation volume, as measured by the flow meter.
doi:10.1371/journal.pone.0095823.g006
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large sample size (n = 12, Figure 7, D). By comparison, automated
inflation studies provided blood flows with reduced variation
(CV = 0.039 and 0.067) and statistically-significant results, while
requiring fewer animals (n = 7) [26]. A summary of the multi-study
comparison is presented in Table 1.
Discussion
Balloon catheter inflation experiments have been vital for
simulating myocardial ischemia in animal models [16,18,23]. In
these approaches, a catheter balloon is inflated to reduce or
eliminate blood flow to a desired region. Manual approaches for
balloon catheter inflation have been successfully used in previous
studies. However, we have found that manual balloon inflation
requires intermittent-to-constant supervision, depending on the
type of inflation protocol used. As shown (Table 1), the common
method for supplying pressurized air – through a hand-held
syringe – introduces a non-negligible amount of human error into
the inflation protocol, resulting in higher variance in subsequent
collateral dependent blood flow measurements, with coefficients of
variation (CV) of 1 or greater. Also, some aspects of manual
balloon catheter inflation (such as the rate of inflation and
deflation) are operator dependent, and hence, difficult to
reproduce in varied settings. Because of all of these reasons, we
have designed the automated balloon catheter inflation device
reported here, which reduces the need for operator supervision,
increases the reproducibility of balloon inflation, and allows multi-
week experimental protocols to be performed. We have controlled
the balloon catheter inflation device with a software package that
allows for easy set-up and alteration of the inflation protocol, as
Figure 7. Collateral dependent blood flow measurements made after transient repetitive myocardia ischemia (RI) studies using the
automated balloon catheter inflation device described in this manuscript displayed greatly reduced variance compared to blood
flow measurements made after transient ischemia using manual inflation. Blood flow measurements made in WKY rats after using the
automated inflation device (A–C) not only displayed greatly reduced variance than our previous manual inflation studies (compare to Figure 2 in
Toyota, et al., 2005) [23], but also required fewer animals to complete a similar study (n = 3 or n = 6, compared to n = 9, for a study group). Note that
panel C represents data from panels A and B combined. Similarly, blood flow measurements made in SD rats after manual inflation (D, E) had such
high variance that they were not statistically significant (even with an n = 12), while measurements made after automated inflation (compare to
Figure 7 in Dodd, et al., 2011 and Figure 4C in Hutcheson, et al., 2013) [24] achieved a high level of significance (p,0.05) with fewer animals (n = 5 and
n = 7, respectively). A summary of results with coefficients of variation is given in Table 1.
doi:10.1371/journal.pone.0095823.g007
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well as monitoring of the progress of the inflation protocol and an
estimate of the volume of pressurized air delivered to the balloons.
This device has resulted in reduced variation in collateral
dependent blood flow measurements. The highest CV reported
with automated inflation was 0.470, which was measured at
conditions of very low blood flow rate (likely close to the
instrumentation error of the flow measurement technique). All
other CVs for automated inflation were ,0.1. By contrast, CVs
for manual inflation ranged from 0.436–1.038. It should also be
noted that, in both WKY and SD rats, fewer animals were
required for each study using automated inflation, while still
yielding blood flow measurements with decreased CVs.
The automated balloon catheter inflation device that we have
developed provides several significant advantages over previous
manual inflation studies. First, collateral dependent blood flow
measurements made after using automated inflation have greatly
reduced variance when compared to those made after manual
inflation (Figure 7 and Table 1). Second, this reduced variance has
allowed us to reduce the number of animals needed to achieve
statistically-significant results, and hence has allowed a decreased
morbidity (mortality) rate associated with transient ischemia
studies. Third, automated inflation has significantly reduced the
number of man-hours required to complete an animal study –
both due to the need for less monitoring and interaction with
animals and due to a fewer number of animals needed. Finally, we
anticipate that automated balloon catheter inflation greatly
reduces the potential for over-inflation of the balloon, which
may serve to better preserve the mechanical integrity of the
balloon. Consistent mechanical integrity may, in turn, be one of
the factors leading to reduced variance among animals with
automated balloon catheter inflation. While beyond the scope of
this study, the integrity of the balloon catheter could be assessed
using stress-strain testing and a load failure analysis.
The automated balloon catheter inflation device costs roughly
$1,200–$2,000 (US) to build, depending on the availability of parts
(listed in Table S1) and technical support. Hence, this represents a
very economical investment, when compared to the number of
man-hours required for a single, multi-week catheter inflation
protocol (which is usually repeated multiple times for statistical
significance). Although routine monitoring of any animal protocol
is necessary, using an automated inflation device reduced the need
for human supervision from hourly to daily. In addition, the
dependence of the accuracy of the protocol on operator
interaction was largely eliminated.
The volumetric flowrate that was measured (by integrating the
flowmeter signal) represents an estimate of the total volume
delivered to all four balloon catheters. However, because of
changes in pressure, and because of the compliance of catheter
lines and connecting tubing, this measured volume was not
interpreted as an absolute volume of air delivered, but was rather
used to verify the reproducibility of the device. Because the balloon
catheters are pressurized in parallel, it should also be noted that
the volume expansion of each balloon catheter may vary,
depending on manufacturing differences in the balloon. In our
previous work, we have seen significant manufacturing variation in
balloon volume. Hence, prior to beginning an animal protocol, it
is important to test each of the balloon catheters used. The
automated inflation device we have developed also aids in this pre-
experimental testing, a multiple balloons can be simultaneously
inflated and their volumes compared. In addition, a series of rapid
inflation/deflation cycles can be run to check for defects in the
balloons or catheter lines. It should also be noted that this device
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catheter lines by replacing the pressure manifold with a manifold
having more ports.
The automated inflation device was controlled through a
custom Labview program with user interface. This program was
compiled as an executable, to allow easy access by users and to
allow the program to be installed on multiple PCs. However, it
should be noted that the executable still requires a deployable
version of Labview with associated virtual instrument libraries.
Because of this, there is some amount of computational overhead
required to run the automated inflation device software. If very
high speed inflation/deflation cycles were required (on the order of
ms-ms), it would be advisable to develop a stand-alone version of
the software, that did not require the overhead of the deployable
version of Labview. However, for the time scales of most studies
(inflation times of seconds), the Labview-based software we have
developed provides more-than-adequate response speed and
reproducibility.
Conclusion
The ability to repetitively occlude the coronary artery is critical
to the use of animal models for transient coronary ischemia. In our
previous work, we have found that repeated occlusion of the
coronary artery through manual inflation of balloon catheters can
achieve reproducible changes in collateral dependent blood flow.
However, relatively large numbers of animals and man-hours were
often required to achieve statistical significance, and a high level of
variance was often noted among study animals. In this work, we
have developed a device for repetitive automated inflation of
balloon catheters. We have also compared manual and automated
inflation studies and shown that studies using this automated
inflation device have demonstrated greatly reduced variance,
reduced need for animals, and reduced man-hours to complete a
given study. We have fully documented the parts, equipment,
procedures, and software needed, enabling the automated inflation
device to be constructed by technical or engineering staff at most
institutions. Finally, in addition to the reduced variance, reduced
need for animals, and reduced man-hours required to complete a
study, adoption of automated inflation protocols using this (or
similar) device should result in enhanced data quality in the field of
transient ischemia studies and a better ability to compare results
amongst research groups.
Supporting Information
Figure S1 Labview back panel. The main portion of the
software consists of a series of ‘‘filmstrip’’ timing loops, indicated
by the thick lines with squares.
(TIF)
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